University Of Verona

PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.

Adults with overweight or obesity had improved aerobic capacity and muscle strength after 6 months of supervised Nordic walking and maintained the improvements during 6 months of unsupervised training, according to study data.